Patents by Inventor Adan Rios

Adan Rios has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8623595
    Abstract: Azido-diarylpyrimidine (azido-DAPY) compounds, and compositions containing such compounds, are provided. In addition, methods of using azido-diarylpyrimidines to inactivate reverse transcriptases, prepare inactivated viruses, and treat or prevent viral infections are also provided.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: January 7, 2014
    Assignee: Photoimmune Biotechnology Inc.
    Inventor: Adan Rios
  • Patent number: 8367315
    Abstract: Azido-diarylpyrimidine (azido-DAPY) compounds, and compositions containing such compounds, are provided. In addition, methods of using azido-diarylpyrimidines to inactivate reverse transcriptases, prepare inactivated viruses, and treat or prevent viral infections are also provided.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: February 5, 2013
    Inventor: Adan Rios
  • Publication number: 20130004534
    Abstract: Azido-diarylpyrimidine (azido-DAPY) compounds, and compositions containing such compounds, are provided. In addition, methods of using azido-diarylpyrimidines to inactivate reverse transcriptases, prepare inactivated viruses, and treat or prevent viral infections are also provided.
    Type: Application
    Filed: September 11, 2012
    Publication date: January 3, 2013
    Inventor: Adan Rios
  • Publication number: 20110217331
    Abstract: Azido-diarylpyrimidine (azido-DAPY) compounds, and compositions containing such compounds, are provided. In addition, methods of using azido-diarylpyrimidines to inactivate reverse transcriptases, prepare inactivated viruses, and treat or prevent viral infections are also provided.
    Type: Application
    Filed: March 5, 2010
    Publication date: September 8, 2011
    Inventor: Adan Rios
  • Patent number: 7727757
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation. The inactivated virus may be more safely handled, stored, and analyzed, used in diagnostic procedures and kits, and may be used as an immunogen to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Grant
    Filed: September 22, 2003
    Date of Patent: June 1, 2010
    Inventor: Adan Rios
  • Publication number: 20040057930
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation. The inactivated virus may be more safely handled, stored, and analyzed, used in diagnostic procedures and kits, and may be used as an immunogen to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Application
    Filed: September 22, 2003
    Publication date: March 25, 2004
    Inventor: Adan Rios
  • Patent number: 6653130
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation used to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Grant
    Filed: May 6, 2002
    Date of Patent: November 25, 2003
    Inventor: Adan Rios
  • Patent number: 6649410
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation. The inactivated virus may be more safely handled, stored, and analyzed, used in diagnostic procedures and kits, and may be used as an immunogen to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: November 18, 2003
    Inventor: Adan Rios
  • Publication number: 20030129200
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation used to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Application
    Filed: May 6, 2002
    Publication date: July 10, 2003
    Inventor: Adan Rios
  • Publication number: 20030104011
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation. The inactivated virus may be more safely handled, stored, and analyzed, used in diagnostic procedures and kits, and may be used as an immunogen to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Application
    Filed: December 30, 2002
    Publication date: June 5, 2003
    Inventor: Adan Rios
  • Patent number: 6503753
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation. The inactivated virus may be more safely handled, stored, and analyzed, used in diagnostic procedures and kits, and may be used as an immunogen to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: January 7, 2003
    Inventor: Adan Rios
  • Patent number: 6383806
    Abstract: Human immunodeficiency virus (HIV) comprising reverse transcriptase inactivated by photoinactivation used to evoke an immune response. The immune response may protect an individual from challenges with live virus. Alternatively, the inactivated HIV particles may be used to augment the immune response to HIV in an infected individual.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: May 7, 2002
    Inventor: Adan Rios